Bedfont Scientific clears FDA follow-up audit

Bedfont Scientific, based in Harrietsham Kent, successfully passes another FDA inspection.

Bedfont Scientific, a local medical device manufacturer specialising in breath analysis, is pleased to announce that the US Food and Drug Administration (FDA) has completed a successful inspection at its premises.

The audit found Bedfont to be compliant with Good Manufacturing Practice (GMP), which means their products are manufactured to the highest quality which is essential when you’re providing technology that saves people’s lives.

We are really pleased the FDA follow-up audit went well and all previous observations were closed out. With this outcome, it shows we are working as a compliant company to FDA standards and are able to continue to provide high-quality products to the USA. We look forward to working with the FDA in the future and to continue building on our relationship with them.

Louise Bateman, QA & RA Manager at Bedfont Scientific.

Bedfont’s aim for the future with this clean bill of health is to continue with our scientific contributions to health, including research and development into new medical breath analysis applications, to help save peoples' lives, one breath at a time.

General Manager, Jason Smith.